Skip to content

Author

Y. Shimura

We have 1 of 152 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Jul 2026

The PDPK1–RSK2 axis as a potential convergent therapeutic vulnerability in B-cell lymphomas

Targeting a shared signaling pathway might help overcome resistance seen with traditional precision medicine and support the development of new therapies for rare disease subtypes, despite their genetic and phenotypic differences.

Junya Kuroda, T. Tsukamoto, Y. Shimura · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.